Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Clients of BWMK’s Elizabeth Kaveny File for $100 Million NECC Victim Compensation Fund and Others Urged to File Immediately Prior to the January 15, 2014 Deadline
  • USA - English


News provided by

Burke Wise Morrissey Kaveny

Jan 10, 2014, 13:35 ET

Share this article

Share toX

Share this article

Share toX

Elizabeth Kaveny, Partner Burke Wise Morrissey Kaveny - Chicago, IL
Elizabeth Kaveny, Partner Burke Wise Morrissey Kaveny - Chicago, IL

I urge anyone with a potential claim to contact us immediately to help ensure that they receive the compensation they’re entitled to for the pain and suffering they endured.

Post this

Chicago, IL (PRWEB) January 10, 2014 -- Elizabeth (Beth) Kaveny, name partner in noted Chicago personal injury law firm Burke Wise Morrissey Kaveny (BWMK) discusses the sequence of events surrounding 2012 fungal meningitis outbreak allegedly traced to New England Compounding Center (NECC) and its effect on her clients. She urges other victims to consider filing for compensation from the $100 million victim and creditor fund established by NECC’s insurers and its bankruptcy trustee. Wednesday, January 15, 2014 is the deadline for submitting proof of claim against the fund as part of the NECC bankruptcy proceeding (1).

On February 13, 2013, BWMK announced via its website that Partner Elizabeth Kaveny was one of the first attorneys in the country to file suit against NECC on behalf of a number of people in Michigan (the state hit hardest by the outbreak) who were victims in the outbreak of fungal meningitis traced to contaminated steroid injections alleged produced by the company – creating a major product liability crisis involving this widely used medical product. On November 13, 2012, Ms. Kaveny spoke candidly about the extent of situation in an interview with NBC News.com in connection with her cases, which were transferred to Multidistrict Litigation against NECC. Ms. Kaveny’s clients are among those entitled to compensation from the NECC victim fund.

According to an October 23, 2013 report from the Centers for Disease Control and Prevention (CDC), more than 750 people were stricken and 64 people died in the 20-state fungal meningitis outbreak. The outbreak was first reported on September 18, 2012, and ultimately was traced to contaminated product shipped by NECC as early as May 2012.(3) By October 6, 2012 NECC began a product recall for the injections it had shipped, but ultimately the CDC and other governmental authorities had to notify more than 13,500 people that they potentially were at risk from the contaminated products.(3) NECC filed for Chapter 11 in December of 2012. (2) In January 2013, U.S. Bankruptcy Judge Henry Boroff froze the assets of NECC and its owners.(4)

On November 27, 2013 President Obama signed new legislation that subjects large compounding operations such as NECC to direct federal regulation by the Food and Drug Administration (FDA), rather than by state pharmacy boards that have previously overseen these companies. It also sets minimum standards for ingredients used by all compounding pharmacies.(5) Beth Kaveny, strongly in favor of such FDA regulation of large compounding pharmacies said, “We should not forget that sadly it is only on the death and suffering of my clients that we all will benefit from higher scrutiny forced upon the FDA." She also emphasized why such regulation is necessary, pointing out that “the 'F' in the FDA’s name should also remind us that it is an arm of the federal government, and that the government must step up to its responsibility to ensure that such a disaster does not happen again.”

NECC cases have been consolidated into an MDL currently pending in the Federal District Court of Massachusetts,1:13-md-02419. The NECC victim compensation pool will be funded by cash contributions from the owners of NECC as well as proceeds from, among other things, insurance, tax refunds and proceeds from the sale of a related business. The Bankruptcy Court, case number 12-19882-HJB, has been asked to confirm a plan containing the terms of the settlement agreement creating the compensation fund.

“Establishing the NECC victim compensation fund is an important step in seeing that justice is done for all victims including my clients,” Ms Kaveny said. “I urge anyone with a potential claim to contact us immediately to help ensure that they receive the compensation they’re entitled to for the pain and suffering they endured.”

Anyone still interested in filing a claim should contact Beth Kaveny or her associate, David Rashid, immediately. Call Beth or David at 312-5802040. Email Beth at eak(at)bwmklaw(dot)com, or email David at djr(at)bwmklaw(dot)com.

Ms. Kaveny, during her professional career has obtained numerous verdicts and settlements of plaintiff personal injury and professional malpractice actions, each in excess of $1 million and some at more than $10 million. She is widely respected for her success at securing just compensation for her clients in such complex, medically related matters as misdiagnosis and failure to diagnose and has been recognized by Illinois Leading Lawyers Network and Illinois SuperLawyers as one of the state's top personal injury attorneys. She was most recently recognized by selection as one of the “Top Women Attorneys in Illinois” by Thomson Reuters and Chicago Magazine in October 2013, and featured among the rising stars in the Chicago personal injury bar by Crain’s Chicago Business in September 2013.

About Burke Wise Morrissey Kaveny
Burke Wise Morrissey Kaveny, Chicago based plaintiff personal injury firm, has for nearly 20 years represented victims of negligence and their families in a wide range of liability litigation. The firm's broad knowledge, and extensive trial and mediation experience, have been instrumental in verdicts and settlements for clients valued in the hundreds of millions of dollars, including over $50 million dollars in 2013 and over $800 million in the past decade.

Attorney Contact: Elizabeth Kaveny, eak(at)bwmklaw(dot)com, 312-580-2040

Media Contact: Denise M. Henderson; denisemhenderson(at)aol(dot)com 312-848-0067

Sources:

(1) CBSnews.com 12/24/14 - http://www.cbsnews.com/news/meningitis-victims-nearing-settlement-with-new-england-compounding-center-for-100m/

(2) CNN.com 12/21/12 – http://www.cnn.com/2012/12/21/health/massachusetts-meningitis-bankruptcy/index.html?iref=allsearch

(3) CDC.org – 3/25/13 event dates source
http://www.cdc.gov/hai/outbreaks/infographic.html

(4) Reuters 1/28/13 – Judge Freezes NECC assets
http://mobile.reuters.com/article/healthNews/idUSBRE90R0XI20130128

(5) NBCNews.com 11/27/13 http://www.nbcnews.com/health/obama-signs-bill-regulating-compounding-pharmacies-2D11665035

Elizabeth Kaveny, Burke Wise Morrissey Kaveny, http://www.bwmklaw.com, +1 312-580-2040, [email protected]

Modal title

Burke Wise Morrissey Kaveny - WWW.BWMKLaw.com
Burke Wise Morrissey Kaveny - WWW.BWMKLaw.com
Burke Wise Morrissey Kaveny - WWW.BWMKLaw.com

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.